Emmaus Life Sciences, Inc. (EMMA) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist RSJ Private Equity Investment Fund with variable registered capital, a.s. mit 37,000,000 Aktien. Weitere bedeutende Anteilseigner sind Niihara Yutaka und SCHINDLER WALTER.
EMMA Insider-Beteiligungen
Größter Aktionär
RSJ Private Equity Investment Fund with variable registered capital, a.s.
37,000,000 Aktien
Käufe (12 Monate)
0
$0.00 Wert
Verkäufe (12 Monate)
0
$0.00 Wert
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Rsj Private Equity Investment Fund With Variable Registered Capital, A.s. |
10 Percent Owner |
37,000,000 |
2016-09-15 |
|
| 2 |
Niihara Yutaka |
Chairman and CEO |
11,990,757 |
2022-12-01 |
|
| 3 |
Schindler Walter |
Director |
6,069,376 |
2014-07-14 |
|
| 4 |
Lim Seah H. |
Director |
4,606,626 |
2024-09-18 |
|
| 5 |
Oman Mark C |
10 Percent Owner |
4,000,000 |
2015-12-28 |
|
| 6 |
Pappajohn John |
10 Percent Owner |
1,117,925 |
2019-05-23 |
|
| 7 |
Rsj Investments Sicav A.s. Acting In Respect Of Its Sub-fund (podfond) Rsj Gradus Podfond, Rsj Investment Sicav A.s. |
10 Percent Owner |
1,056,474 |
2018-11-21 |
|
| 8 |
Hertz Horace |
CFO |
651,250 |
2007-08-10 |
|
| 9 |
Harbin Henry T |
Director |
650,000 |
2010-03-05 |
|
| 10 |
Rsj Investments Sicav A.s. |
10 Percent Owner |
625,704 |
2017-03-22 |
|
| 11 |
Hoffman Daniel A |
President and CMO |
500,000 |
2010-03-05 |
|
| 12 |
Thompson Tommy G |
Director |
400,000 |
2010-03-05 |
|
| 13 |
Herguth Patrick |
Chief Executive Officer |
400,000 |
2018-12-14 |
|
| 14 |
Luce Bradley |
V.p. Finance & Controller |
275,000 |
2009-02-09 |
|
| 15 |
Turner Richard W |
Director |
250,000 |
2013-05-28 |
|
| 16 |
Vaccaro Jerome |
Director |
250,000 |
2010-03-05 |
|
| 17 |
Tierney Thomas T |
10 Percent Owner |
216,345 |
2016-12-02 |
|
| 18 |
Nagasaki Yasushi |
CFO |
200,000 |
2024-02-05 |
|
| 19 |
Sekulich George |
Co-president & Cco |
200,000 |
2024-02-05 |
|
| 20 |
Stark Charles William |
CSO & EVP Clinical Development |
200,000 |
2024-02-05 |
|
Keine Beteiligungsdaten für EMMA verfügbar.